FMR1 and fragile X syndrome: Induced pluripotent stem cells (iPSCs) of patients with fragile X syndrome in theFRX gene upstream of the CGH repeat were targeted with expressed CRISPR–Cas9 nuclease along with single guide RNA (sgRNA) and resulted in the reactivation of the FMR1 protein66.